| 1 |
Potential drug–drug Interactions in hospitalized cancer patients: A report from the Middle-East |
|
|
| Azadeh Moghaddas, Mohammad Adib-Majlesi, Ali M Sabzghabaee, Ali Hajigholami, Rachel Riechelmann |
|
| Journal of Oncology Pharmacy Practice. 2021; 27(1): 46 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Drug therapy problems and health related quality of life among patients with colorectal cancer in a Kenyan tertiary health facility |
|
|
| Charles M Kabiru, Peter N Karimi, David G Nyamu, Irene W Weru |
|
| Journal of Oncology Pharmacy Practice. 2021; 27(2): 428 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients |
|
|
| Rashida Muhammad Umar, Sule Apikoglu-Rabus, Perran Fulden Yumuk |
|
| International Journal of Clinical Pharmacy. 2020; 42(2): 652 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors |
|
|
| Mª Ángeles Fernández de Palencia Espinosa,Mª Sacramento Díaz Carrasco,José Luis Alonso Romero,Amelia de la Rubia Nieto,Alberto Espuny Miró |
|
| International Journal of Clinical Pharmacy. 2015; 37(6): 1021 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Medication misuse in India: a major public health issue in India |
|
|
| G. Porter,N. Grills |
|
| Journal of Public Health. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Drug–drug interactions in HIV positive cancer patients |
|
|
| Brian Thabile Flepisi,Patrick Bouic,Gerhard Sissolak,Bernd Rosenkranz |
|
| Biomedicine & Pharmacotherapy. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East |
|
|
| Safoora Gholaminezhad,Molouk Hadjibabaie,Kheirollah Gholami,Mohammad Reza Javadi,Mania Radfar,Iman Karimzadeh,Ardeshir Ghavamzadeh |
|
| Annals of Hematology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Potential drug–drug interactions at a referral hematology–oncology ward in Iran: a cross-sectional study |
|
|
| Molouk Hadjibabaie,Shirinsadat Badri,Sarah Ataei,Amir Hossein Moslehi,Iman Karimzadeh,Ardeshir Ghavamzadeh |
|
| Cancer Chemotherapy and Pharmacology. 2013; 71(6): 1619 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Medication surveillance on intravenous cytotoxic agents: a retrospective study |
|
|
| Brigit Oijen,Rob Janknegt,Hugo Wit,Frank Peters,Harry Schouten,Hugo Kuy |
|
| International Journal of Clinical Pharmacy. 2013; 35(4): 554 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Medication surveillance on intravenous cytotoxic agents: A retrospective study |
|
|
| Van Oijen, B. and Janknegt, R. and De Wit, H. and Peters, F. and Schouten, H. and Van Der Kuy, H. |
|
| International Journal of Clinical Pharmacy. 2013; 35(4): 554-559 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Potential drug-drug interactions at a referral hematology-oncology ward in Iran: A cross-sectional study |
|
|
| Hadjibabaie, M. and Badri, S. and Ataei, S. and Moslehi, A.H. and Karimzadeh, I. and Ghavamzadeh, A. |
|
| Cancer Chemotherapy and Pharmacology. 2013; 71(6): 1619-1627 |
|
| [Pubmed] [Google Scholar] |
|
